Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study
Phase of Trial: Phase III
Latest Information Update: 23 Mar 2018
Price : $35 *
At a glance
- Drugs Adalimumab (Primary) ; Methotrexate
- Indications Psoriasis
- Focus Therapeutic Use
- Acronyms CLEAR
- Sponsors AbbVie
- 31 Aug 2018 Biomarkers information updated
- 20 Mar 2017 Status changed from active, no longer recruiting to completed.
- 16 Jan 2017 Status changed from recruiting to active, no longer recruiting.